Switch to:
Also traded in: Argentina, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.66
CAH's Cash-to-Debt is ranked lower than
73% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.60 vs. CAH: 0.66 )
Ranked among companies with meaningful Cash-to-Debt only.
CAH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.02  Med: 0.46 Max: 3.34
Current: 0.66
0.02
3.34
Equity-to-Asset 0.17
CAH's Equity-to-Asset is ranked lower than
87% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.41 vs. CAH: 0.17 )
Ranked among companies with meaningful Equity-to-Asset only.
CAH' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.17  Med: 0.35 Max: 0.5
Current: 0.17
0.17
0.5
Debt-to-Equity 1.53
CAH's Debt-to-Equity is ranked lower than
75% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.50 vs. CAH: 1.53 )
Ranked among companies with meaningful Debt-to-Equity only.
CAH' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04  Med: 0.46 Max: 1.55
Current: 1.53
0.04
1.55
Interest Coverage 10.55
CAH's Interest Coverage is ranked higher than
57% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.51 vs. CAH: 10.55 )
Ranked among companies with meaningful Interest Coverage only.
CAH' s Interest Coverage Range Over the Past 10 Years
Min: 5.89  Med: 11.51 Max: 15.33
Current: 10.55
5.89
15.33
Piotroski F-Score: 4
Altman Z-Score: 4.18
Beneish M-Score: -2.45
WACC vs ROIC
6.21%
14.05%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 1.63
CAH's Operating Margin % is ranked lower than
70% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.80 vs. CAH: 1.63 )
Ranked among companies with meaningful Operating Margin % only.
CAH' s Operating Margin % Range Over the Past 10 Years
Min: 0.99  Med: 1.61 Max: 2.11
Current: 1.63
0.99
2.11
Net Margin % 0.99
CAH's Net Margin % is ranked lower than
64% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.80 vs. CAH: 0.99 )
Ranked among companies with meaningful Net Margin % only.
CAH' s Net Margin % Range Over the Past 10 Years
Min: 0.33  Med: 1.08 Max: 1.49
Current: 0.99
0.33
1.49
ROE % 19.61
CAH's ROE % is ranked higher than
89% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.49 vs. CAH: 19.61 )
Ranked among companies with meaningful ROE % only.
CAH' s ROE % Range Over the Past 10 Years
Min: 5.47  Med: 17.46 Max: 22.28
Current: 19.61
5.47
22.28
ROA % 3.62
CAH's ROA % is ranked higher than
52% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.76 vs. CAH: 3.62 )
Ranked among companies with meaningful ROA % only.
CAH' s ROA % Range Over the Past 10 Years
Min: 1.33  Med: 4.46 Max: 5.58
Current: 3.62
1.33
5.58
ROC (Joel Greenblatt) % 71.92
CAH's ROC (Joel Greenblatt) % is ranked higher than
89% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 23.31 vs. CAH: 71.92 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
CAH' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 19.21  Med: 59.35 Max: 124.13
Current: 71.92
19.21
124.13
3-Year Revenue Growth Rate 15.40
CAH's 3-Year Revenue Growth Rate is ranked lower than
51% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.00 vs. CAH: 15.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CAH' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -4.7  Med: 13.5 Max: 43.9
Current: 15.4
-4.7
43.9
3-Year EBITDA Growth Rate 9.30
CAH's 3-Year EBITDA Growth Rate is ranked higher than
85% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.40 vs. CAH: 9.30 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
CAH' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -11.7  Med: 9.5 Max: 78.2
Current: 9.3
-11.7
78.2
3-Year EPS without NRI Growth Rate 6.10
CAH's 3-Year EPS without NRI Growth Rate is ranked higher than
95% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.40 vs. CAH: 6.10 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CAH' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -15.7  Med: 13.4 Max: 64.5
Current: 6.1
-15.7
64.5
GuruFocus has detected 2 Warning Signs with Cardinal Health Inc $CAH.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CAH's 30-Y Financials

Financials (Next Earnings Date: 2017-10-31 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

CAH Guru Trades in Q3 2016

Mairs and Power 2,891 sh (New)
Jim Simons 261,600 sh (+106.96%)
Scott Black 14,767 sh (+37.50%)
Barrow, Hanley, Mewhinney & Strauss 16,250,027 sh (+29.79%)
Vanguard Health Care Fund 6,385,231 sh (unchged)
First Pacific Advisors 98,560 sh (unchged)
Steven Cohen Sold Out
John Buckingham 15,490 sh (-0.39%)
Arnold Van Den Berg 76,190 sh (-1.47%)
Pioneer Investments 1,506,937 sh (-16.58%)
Joel Greenblatt 591,857 sh (-22.97%)
Ray Dalio 97,257 sh (-32.26%)
Paul Tudor Jones 3,095 sh (-87.02%)
» More
Q4 2016

CAH Guru Trades in Q4 2016

David Dreman 2,278 sh (New)
Seth Klarman 1,030,000 sh (New)
John Rogers 36,526 sh (New)
Paul Tudor Jones 7,600 sh (+145.56%)
Barrow, Hanley, Mewhinney & Strauss 21,364,753 sh (+31.48%)
Ray Dalio 124,000 sh (+27.50%)
John Buckingham 19,441 sh (+25.51%)
Arnold Van Den Berg 94,697 sh (+24.29%)
Scott Black 14,837 sh (+0.47%)
Vanguard Health Care Fund 6,385,231 sh (unchged)
Mairs and Power 2,891 sh (unchged)
First Pacific Advisors 98,560 sh (unchged)
Jim Simons Sold Out
Pioneer Investments 321,926 sh (-78.64%)
Joel Greenblatt 74,164 sh (-87.47%)
» More
Q1 2017

CAH Guru Trades in Q1 2017

Richard Pzena 1,059,303 sh (New)
John Rogers 746,789 sh (+1944.54%)
Mairs and Power 2,981 sh (+3.11%)
John Buckingham 19,875 sh (+2.23%)
Seth Klarman 1,030,000 sh (unchged)
David Dreman Sold Out
Joel Greenblatt Sold Out
Paul Tudor Jones Sold Out
Scott Black Sold Out
Vanguard Health Care Fund 6,324,531 sh (-0.95%)
Arnold Van Den Berg 92,672 sh (-2.14%)
Barrow, Hanley, Mewhinney & Strauss 20,705,013 sh (-3.09%)
First Pacific Advisors 90,500 sh (-8.18%)
Ray Dalio 46,958 sh (-62.13%)
Pioneer Investments 55,347 sh (-82.81%)
» More
Q2 2017

CAH Guru Trades in Q2 2017

Manning & Napier Advisors, Inc 68,883 sh (New)
Charles Brandes 31,619 sh (New)
Steven Cohen 634,145 sh (New)
David Dreman 12,233 sh (New)
Seth Klarman 2,030,000 sh (+97.09%)
Vanguard Health Care Fund 7,522,531 sh (+18.94%)
Mairs and Power 3,434 sh (+15.20%)
John Buckingham 22,297 sh (+12.19%)
Barrow, Hanley, Mewhinney & Strauss 20,846,948 sh (+0.69%)
Pioneer Investments Sold Out
Ray Dalio Sold Out
Richard Pzena 1,058,804 sh (-0.05%)
Arnold Van Den Berg 91,167 sh (-1.62%)
John Rogers 661,475 sh (-11.42%)
First Pacific Advisors 52,300 sh (-42.21%)
» More
» Details

Insider Trades

Latest Guru Trades with CAH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Barrow, Hanley, Mewhinney & Strauss 2017-06-30 Add 0.69%0.02%$71.6 - $82.71 $ 66.66-12%20,846,948
Vanguard Health Care Fund 2017-06-30 Add 18.94%0.2%$71.6 - $82.71 $ 66.66-12%7,522,531
Seth Klarman 2017-06-30 Add 97.09%0.9%$71.6 - $82.71 $ 66.66-12%2,030,000
Richard Pzena 2017-06-30 Reduce -0.05%$71.6 - $82.71 $ 66.66-12%1,058,804
John Rogers 2017-06-30 Reduce -11.42%0.08%$71.6 - $82.71 $ 66.66-12%661,475
Arnold Van Den Berg 2017-06-30 Reduce -1.62%0.02%$71.6 - $82.71 $ 66.66-12%91,167
Charles Brandes 2017-06-30 New Buy0.04%$71.6 - $82.71 $ 66.66-12%31,619
David Dreman 2017-06-30 New Buy0.52%$71.6 - $82.71 $ 66.66-12%12,233
Barrow, Hanley, Mewhinney & Strauss 2017-03-31 Reduce -3.09%0.07%$72.47 - $83.8 $ 66.66-15%20,705,013
Vanguard Health Care Fund 2017-03-31 Reduce -0.95%0.01%$72.47 - $83.8 $ 66.66-15%6,324,531
Richard Pzena 2017-03-31 New Buy0.49%$72.47 - $83.8 $ 66.66-15%1,059,303
John Rogers 2017-03-31 Add 1944.54%0.68%$72.47 - $83.8 $ 66.66-15%746,789
Arnold Van Den Berg 2017-03-31 Reduce -2.14%0.02%$72.47 - $83.8 $ 66.66-15%92,672
David Dreman 2017-03-31 Sold Out 0.09%$72.47 - $83.8 $ 66.66-15%0
Joel Greenblatt 2017-03-31 Sold Out 0.07%$72.47 - $83.8 $ 66.66-15%0
Barrow, Hanley, Mewhinney & Strauss 2016-12-31 Add 31.48%0.56%Premium Member Access $71.97 $ 66.66-7%21,364,753
Barrow, Hanley, Mewhinney & Strauss 2016-12-31 Add 31.48%0.55%$65.17 - $76.71 $ 66.66-8%21,364,753
Seth Klarman 2016-12-31 New Buy0.98%$65.17 - $76.71 $ 66.66-8%1,030,000
Arnold Van Den Berg 2016-12-31 Add 24.29%0.21%$65.17 - $76.71 $ 66.66-8%94,697
Joel Greenblatt 2016-12-31 Reduce -87.47%0.52%$65.17 - $76.71 $ 66.66-8%74,164
John Rogers 2016-12-31 New Buy0.03%$65.17 - $76.71 $ 66.66-8%36,526
David Dreman 2016-12-31 New Buy0.09%$65.17 - $76.71 $ 66.66-8%2,278
Barrow, Hanley, Mewhinney & Strauss 2016-09-30 Add 29.79%0.44%$75.26 - $84.92 $ 66.66-18%16,250,027
Joel Greenblatt 2016-09-30 Reduce -22.97%0.17%$75.26 - $84.92 $ 66.66-18%591,857
Arnold Van Den Berg 2016-09-30 Reduce -1.47%0.01%$75.26 - $84.92 $ 66.66-18%76,190
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Distribution » Medical Distribution    NAICS: 424210    SIC: 5122
Compare:NYSE:ABC, NAS:HSIC, NYSE:MCK, NAS:PDCO, NYSE:PBH, NYSE:OMI, NYSE:PMC, OTCPK:SNYR, OTCPK:FZMD » details
Traded in other countries:CAH.Argentina, CLH.Germany,
Headquarter Location:USA
Cardinal Health Inc is a healthcare services company. It provides services and products for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices.

Cardinal Health is a major distributor of pharmaceuticals and medical supplies to pharmacies and hospitals. Its operations include procurement, packaging, inventory management, and logistics services. Its largest customer is CVS Health retail pharmacy operatons.

Top Ranked Articles about Cardinal Health Inc

David Dreman’s Top 5 Health Care Buys for the 2nd Quarter Guru takes new positions in stocks he previously sold
Dreman Value Management founder David Dreman (Trades, Portfolio) established 210 new positions in the second quarter, of which 20 were in health care companies. His top five health care buys were Aetna Inc. (NYSE:AET), Zimmer Biomet Holdings Inc. (NYSE:ZBH), Amgen Inc. (NASDAQ:AMGN), Biogen Inc. (NASDAQ:BIIB) and Cardinal Health Inc. (NYSE:CAH). Read more...
Cardinal Health Board of Directors Approves Quarterly Dividend
Vanguard Health Care Fund Adds to Multiple Positions The fund built up many positions in the 2nd quarter
The Vanguard Health Care Fund (Trades, Portfolio) increased its holdings of many stocks during the quarter. The eight largest are as follows. Read more...
Cardinal Health Completes Acquisition of Medtronic's Patient Recovery Business
Decreasing the Dosage to Increase Positive Patient Outcomes
John Rogers Buys Cardinal Health, Mattel, Nielsen Guru's largest 1st-quarter buys
John Rogers (Trades, Portfolio) is the founder of Ariel Investment LLC, which he started in 1983. He manages a portfolio composed of 188 stocks with a total value of $8.505 billion. During the first quarter the guru bought shares in the following stocks: Read more...
Research-Based Insights on Oncology Published by Cardinal Health Specialty Solutions
Patient Safety Advocate Earned Cardinal Health urEssential Laboratory Professional of the Year Award
Richard Pzena Invests in 3 Health Care Companies Guru releases 1st-quarter portfolio
Richard Pzena (Trades, Portfolio) gained 14 new holdings during the first quarter. Among them were three health care stocks, including Mylan NV(NASDAQ:MYL), Cardinal Health Inc. (NYSE:CAH) and Biogen Inc. (NASDAQ:BIIB). Read more...
Cardinal Health Board of Directors Approves Quarterly Dividend

Ratios

vs
industry
vs
history
PE Ratio 16.50
CAH's PE Ratio is ranked higher than
58% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 20.11 vs. CAH: 16.50 )
Ranked among companies with meaningful PE Ratio only.
CAH' s PE Ratio Range Over the Past 10 Years
Min: 6.29  Med: 15.93 Max: 73.78
Current: 16.5
6.29
73.78
Forward PE Ratio 13.14
CAH's Forward PE Ratio is ranked higher than
60% of the 15 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.51 vs. CAH: 13.14 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 16.50
CAH's PE Ratio without NRI is ranked higher than
59% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.11 vs. CAH: 16.50 )
Ranked among companies with meaningful PE Ratio without NRI only.
CAH' s PE Ratio without NRI Range Over the Past 10 Years
Min: 9.98  Med: 18.71 Max: 74.54
Current: 16.5
9.98
74.54
Price-to-Owner-Earnings 48.98
CAH's Price-to-Owner-Earnings is ranked lower than
84% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 27.03 vs. CAH: 48.98 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
CAH' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 6.22  Med: 14.97 Max: 58.55
Current: 48.98
6.22
58.55
PB Ratio 3.09
CAH's PB Ratio is ranked lower than
73% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.38 vs. CAH: 3.09 )
Ranked among companies with meaningful PB Ratio only.
CAH' s PB Ratio Range Over the Past 10 Years
Min: 0.86  Med: 2.47 Max: 4.76
Current: 3.09
0.86
4.76
PS Ratio 0.16
CAH's PS Ratio is ranked higher than
85% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.91 vs. CAH: 0.16 )
Ranked among companies with meaningful PS Ratio only.
CAH' s PS Ratio Range Over the Past 10 Years
Min: 0.08  Med: 0.17 Max: 0.32
Current: 0.16
0.08
0.32
Price-to-Free-Cash-Flow 26.78
CAH's Price-to-Free-Cash-Flow is ranked lower than
83% of the 24 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.40 vs. CAH: 26.78 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CAH' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 5.82  Med: 12.27 Max: 43.13
Current: 26.78
5.82
43.13
Price-to-Operating-Cash-Flow 18.02
CAH's Price-to-Operating-Cash-Flow is ranked lower than
64% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.51 vs. CAH: 18.02 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CAH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 4.68  Med: 10.38 Max: 24.47
Current: 18.02
4.68
24.47
EV-to-EBIT 11.57
CAH's EV-to-EBIT is ranked higher than
69% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.08 vs. CAH: 11.57 )
Ranked among companies with meaningful EV-to-EBIT only.
CAH' s EV-to-EBIT Range Over the Past 10 Years
Min: 5.3  Med: 11.7 Max: 25.5
Current: 11.57
5.3
25.5
EV-to-EBITDA 8.65
CAH's EV-to-EBITDA is ranked higher than
74% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.22 vs. CAH: 8.65 )
Ranked among companies with meaningful EV-to-EBITDA only.
CAH' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.5  Med: 9.35 Max: 17.6
Current: 8.65
4.5
17.6
EV-to-Revenue 0.19
CAH's EV-to-Revenue is ranked higher than
89% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.05 vs. CAH: 0.19 )
Ranked among companies with meaningful EV-to-Revenue only.
CAH' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.1  Med: 0.2 Max: 0.3
Current: 0.19
0.1
0.3
PEG Ratio 1.19
CAH's PEG Ratio is ranked higher than
73% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.21 vs. CAH: 1.19 )
Ranked among companies with meaningful PEG Ratio only.
CAH' s PEG Ratio Range Over the Past 10 Years
Min: 1.06  Med: 3.05 Max: 33.9
Current: 1.19
1.06
33.9
Shiller PE Ratio 20.22
CAH's Shiller PE Ratio is ranked higher than
70% of the 20 Companies
in the Global Medical Distribution industry.

( Industry Median: 34.94 vs. CAH: 20.22 )
Ranked among companies with meaningful Shiller PE Ratio only.
CAH' s Shiller PE Ratio Range Over the Past 10 Years
Min: 6.62  Med: 15.27 Max: 28.92
Current: 20.22
6.62
28.92
Current Ratio 1.34
CAH's Current Ratio is ranked lower than
82% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.49 vs. CAH: 1.34 )
Ranked among companies with meaningful Current Ratio only.
CAH' s Current Ratio Range Over the Past 10 Years
Min: 1.11  Med: 1.57 Max: 2.99
Current: 1.34
1.11
2.99
Quick Ratio 0.80
CAH's Quick Ratio is ranked lower than
93% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.07 vs. CAH: 0.80 )
Ranked among companies with meaningful Quick Ratio only.
CAH' s Quick Ratio Range Over the Past 10 Years
Min: 0.51  Med: 0.74 Max: 1.22
Current: 0.8
0.51
1.22
Days Inventory 33.35
CAH's Days Inventory is ranked higher than
59% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 39.39 vs. CAH: 33.35 )
Ranked among companies with meaningful Days Inventory only.
CAH' s Days Inventory Range Over the Past 10 Years
Min: 25.37  Med: 30.84 Max: 35.34
Current: 33.35
25.37
35.34
Days Sales Outstanding 22.60
CAH's Days Sales Outstanding is ranked higher than
91% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 61.58 vs. CAH: 22.60 )
Ranked among companies with meaningful Days Sales Outstanding only.
CAH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 19.16  Med: 21.73 Max: 23.22
Current: 22.6
19.16
23.22
Days Payable 52.95
CAH's Days Payable is ranked lower than
66% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 69.74 vs. CAH: 52.95 )
Ranked among companies with meaningful Days Payable only.
CAH' s Days Payable Range Over the Past 10 Years
Min: 35.78  Med: 44.33 Max: 54.93
Current: 52.95
35.78
54.93

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 2.70
CAH's Dividend Yield % is ranked higher than
73% of the 63 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.42 vs. CAH: 2.70 )
Ranked among companies with meaningful Dividend Yield % only.
CAH' s Dividend Yield % Range Over the Past 10 Years
Min: 0.63  Med: 1.96 Max: 2.83
Current: 2.7
0.63
2.83
Dividend Payout Ratio 0.45
CAH's Dividend Payout Ratio is ranked lower than
63% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.61 vs. CAH: 0.45 )
Ranked among companies with meaningful Dividend Payout Ratio only.
CAH' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.22  Med: 0.37 Max: 1.12
Current: 0.45
0.22
1.12
3-Year Dividend Growth Rate 13.10
CAH's 3-Year Dividend Growth Rate is ranked higher than
67% of the 27 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.00 vs. CAH: 13.10 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
CAH' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 10.8  Med: 18.6 Max: 51.8
Current: 13.1
10.8
51.8
Forward Dividend Yield % 2.77
CAH's Forward Dividend Yield % is ranked higher than
71% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.54 vs. CAH: 2.77 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 5.43
CAH's 5-Year Yield-on-Cost % is ranked higher than
71% of the 72 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.05 vs. CAH: 5.43 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
CAH' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.27  Med: 3.94 Max: 5.69
Current: 5.43
1.27
5.69
3-Year Average Share Buyback Ratio 2.10
CAH's 3-Year Average Share Buyback Ratio is ranked higher than
89% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: -2.30 vs. CAH: 2.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CAH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -38.9  Med: 0.6 Max: 5.7
Current: 2.1
-38.9
5.7

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 0.95
CAH's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
76% of the 29 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.70 vs. CAH: 0.95 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
CAH' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.3  Med: 1.24 Max: 3.55
Current: 0.95
0.3
3.55
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.32
CAH's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
99.99% of the 10 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.33 vs. CAH: 1.32 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
CAH' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.57  Med: 0.73 Max: 1.55
Current: 1.32
0.57
1.55
Price-to-Median-PS-Value 0.97
CAH's Price-to-Median-PS-Value is ranked lower than
60% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.01 vs. CAH: 0.97 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CAH' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.49  Med: 1.39 Max: 2.8
Current: 0.97
0.49
2.8
Price-to-Peter-Lynch-Fair-Value 1.10
CAH's Price-to-Peter-Lynch-Fair-Value is ranked higher than
62% of the 16 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.68 vs. CAH: 1.10 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
CAH' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.71  Med: 1.37 Max: 4.42
Current: 1.1
0.71
4.42
Earnings Yield (Greenblatt) % 8.64
CAH's Earnings Yield (Greenblatt) % is ranked higher than
75% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.37 vs. CAH: 8.64 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CAH' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 3.9  Med: 8.5 Max: 19
Current: 8.64
3.9
19
Forward Rate of Return (Yacktman) % 22.82
CAH's Forward Rate of Return (Yacktman) % is ranked higher than
80% of the 35 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.37 vs. CAH: 22.82 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
CAH' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 4  Med: 10.5 Max: 23.1
Current: 22.82
4
23.1

More Statistics

Revenue (TTM) (Mil) $129,976.00
EPS (TTM) $ 4.04
Beta0.95
Short Percentage of Float2.50%
52-Week Range $62.70 - 84.88
Shares Outstanding (Mil)315.22

Analyst Estimate

Jun18 Jun19 Jun20
Revenue (Mil $) 137,425 142,875 149,072
EPS ($) 5.19 5.62 6.21
EPS without NRI ($) 5.19 5.62 6.21
EPS Growth Rate
(Future 3Y To 5Y Estimate)
12.63%
Dividends per Share ($) 1.50 1.42 1.42
» More Articles for CAH

Headlines

Articles On GuruFocus.com
David Dreman’s Top 5 Health Care Buys for the 2nd Quarter Aug 25 2017 
Pharmacy Distributor May Be Undervalued Aug 10 2017 
Cardinal Health Board of Directors Approves Quarterly Dividend Aug 09 2017 
Vanguard Health Care Fund Adds to Multiple Positions Aug 01 2017 
Cardinal Health Completes Acquisition of Medtronic's Patient Recovery Business Jul 30 2017 
Decreasing the Dosage to Increase Positive Patient Outcomes Jul 21 2017 
John Rogers Buys Cardinal Health, Mattel, Nielsen Jun 05 2017 
Research-Based Insights on Oncology Published by Cardinal Health Specialty Solutions Jun 01 2017 
Patient Safety Advocate Earned Cardinal Health urEssential Laboratory Professional of the Year Award May 11 2017 
Richard Pzena Invests in 3 Health Care Companies May 09 2017 

More From Other Websites
The Zacks Analyst Blog Highlights: Cardinal Health, Penumbra, STAAR Surgical, Masimo and Smith &... Sep 22 2017
See what the IHS Markit Score report has to say about Cardinal Health Inc. Sep 21 2017
States expand investigation of opioid makers, distributors Sep 19 2017
How Safe Is Cardinal Health's Dividend? Sep 15 2017
New Strong Sell Stocks for September 14th Sep 14 2017
4 Top MedTech Stocks for Dividend Investors in 2017 Sep 08 2017
Why Is Cardinal Health (CAH) Down 2.7% Since the Last Earnings Report? Sep 08 2017
New Mexico sues opioid drug manufacturers, distributors Sep 07 2017
Divestiture of a Part of Medtronic’s PMR Business to Cardinal Health Sep 01 2017
Cramer’s Exec Cut: CEOs reveal how government initiatives... Aug 25 2017
ETFs with exposure to Cardinal Health, Inc. : August 24, 2017 Aug 24 2017
Edited Transcript of CAH earnings conference call or presentation 2-Aug-17 12:30pm GMT Aug 23 2017
Dividend Yield of Cardinal Health Aug 23 2017
Cardinal Health: Cramer's Top Takeaways Aug 23 2017
Cramer Remix: Why these US oil fields may be about to mak... Aug 22 2017
Cramer Remix: Why these US oil fields may be about to make a big market impact Aug 22 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}